Article Text

Download PDFPDF
General and Risk Management, Patient Safety (including: medication errors, quality control)
Analysis of pharmaceutical interventions carried out via electronic prescriptions†
  1. V. Escudero Vilaplana,
  2. C. Capilla Montes,
  3. A.M. Iglesias Bolaños,
  4. T. Cruz Cruz
  1. 1Hospital del Sureste, Pharmacy, Arganda del Rey, Spain


Background Hospital pharmacists play an important role in pharmacotherapy. Pharmaceutical care contributes to securing efficacy and safety in the use of medicines. Validation of the prescriptions allows pharmacists to detect, prevent and solve medicines-related problems.

Purpose To collect and assess the clinical interventions made by a pharmacist in a general public hospital with 120 beds.

Materials and methods Prospective, observational study of hospitalised patients for 2 months. Every day (from July to August 2011) a pharmacist checked the prescriptions electronically. Prescribers were informed of drug-related problems by the electronic prescribing program. Variables collected were: prescriptions written, reason for intervention, the drug involved, acceptance of the intervention by the physicians and response time.

Results 140 interventions were recorded. Patients were mainly admitted to internal medicine (57.9%). Common reasons for interventions were: sequential therapy (55.7%), dose adjustment for renal failure (27.9%), inappropriate dosage (5.0%), missing information or clarification (5.0%), drug duplication (2.1%), excessively long treatment (2.1%) and inappropriate route of administration (2.1%). 38.6% of interventions resulted in a change to patients' pharmacotherapy. Mean response time was 1.1 (SD: 0.9) days. In the majority of non-accepted interventions, the patient's oral tolerability worsened or his/her renal function improved, so no change was required. Drugs most involved were paracetamol: 47.1% (especially in ‘sequential therapy’) and antibiotics: 15.0% (especially in ‘dose adjustment for renal failure’). Potential toxicity was avoided by reducing doses of drugs in 17 patients.

Conclusions The most common intervention was to promote the oral route. This route is safer and less costly than the intravenous route. Patients with renal failure deserved special attention in pharmaceutical validation to avoid toxicity, as the doses of several drugs needed to be adjusted, especially when an antibiotic was prescribed. The drug charts review identified real and potential medication errors.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.